Center for Scientific Review; Amended Notice of Meeting, 7774 [2020-02637]

Download as PDF 7774 Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301–435–1212, kumarra@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 4, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–02637 Filed 2–10–20; 8:45 am] BILLING CODE 4140–01–P Dated: February 5, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2020–02641 Filed 2–10–20; 8:45 am] 2019 Interagency Autism Coordinating Committee Call for Nominations Announcement BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES ACTION: Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, Small Business: HIV/AIDS Innovative Research Applications, March 5, 2020, 12:00 p.m. to 5:00 p.m. at the National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, which was published in the Federal Register on February 05, 2020, 85 FR 6567. The meeting will start at 10:00 a.m. and end at 4:00 p.m. The meeting date and location remain the same. The meeting is closed to the public. Dated: February 5, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–02636 Filed 2–10–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Drug Discovery for the Nervous System Study Section, February 27, 2020 to February 28, 2020, 8:00 a.m. to 6:00 p.m., at the Holiday Inn Bayside, 4875 North Harbor Drive San Diego, CA 92106 which was published in the Federal Register on January 31, 2020, 85 FR 5672. This meeting notice is amended to change the meeting date from February 27–28, 2020 to February 27, 2020. The meeting location and time remain the 18:19 Feb 10, 2020 Jkt 250001 National Institutes of Health, HHS. Center For Scientific Review; Amended Notice of Meeting VerDate Sep<11>2014 National Institutes of Health AGENCY: National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES same. The meeting is closed to the public. Notice. The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on November 26, 2019, seeking nominations of individuals to serve as non-federal public members on the Interagency Autism Coordinating Committee (IACC). The purpose of this Notice is to provide an extension to allow additional time for the acceptance of nominations to the IACC. DATES: Nominations have been extended until Friday, February 21, 2020. ADDRESSES: Nominations are due by Friday February 21, 2020 and may be sent to Dr. Susan Daniels, Director, Office of Autism Research Coordination/NIMH/NIH, 6001 Executive Boulevard, Room 7220, Bethesda, Maryland 20892 by standard or express mail, or via email to IACCPublicInquiries@mail.nih.gov. Confirmation of receipt will be provided. More information about the IACC is available at iacc.hhs.gov. FOR FURTHER INFORMATION CONTACT: Susan Daniels at 301–827–1437 or email at iaccpublicinquiries@mail.nih.gov. SUPPLEMENTARY INFORMATION: On November 26, 2019, the Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on pages 65165– 65166 (84 FR 65165), seeking nominations of individuals to serve as non-federal public members on the Interagency Autism Coordinating Committee (IACC). The closing date for nominations ended on January 17, 2020. The purpose of this notice is to extend acceptance of nominations until February 21, 2020. As specified in the Combating Autism Act of 2006 (Pub. L. 109–416) and reauthorized by the Autism Collaboration, Accountability, SUMMARY: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Research, Education and Support Act of 2019 (Pub. L. 116–60). The Office of the Secretary has directed the Office of Autism Research Coordination (OARC) of the National Institute of Mental Health, National Institutes of Health to assist the Department in conducting an open nomination process. Appointments of non-federal public members to the committee shall be made by the Secretary of Health and Human Services. Eligibility Requirements Nominations of new non-federal public members are encouraged, and current non-federal public members may also be re-nominated to continue to serve if they have served only one term previously, in accordance with the provisions of the Autism CARES Act of 2019. Self-nominations and nominations of other individuals are both permitted. Only one nomination per individual is required. Multiple nominations of the same individual will not increase likelihood of selection. The Secretary may select non-federal public members from the pool of submitted nominations and other sources as needed to meet statutory requirements and to form a balanced committee that represents the diversity within the autism spectrum disorder (ASD) community. Those eligible for nomination include individuals on the autism spectrum, parents or guardians of individuals with ASD, leaders or representatives of major ASD research, advocacy and service organizations, healthcare and service providers, educators, researchers and other individuals with professional or personal experience with ASD. Nominations of individuals with a variety of disability and support needs, individuals from all U.S. states and territories, and individuals representing diverse populations within the autism community, including all genders and gender identities, cultural, ethnic and racial groups are encouraged. Requests for reasonable accommodation to enable participation on the Committee should be indicated in the nomination submission. IACC non-federal public members are appointed as special government employees and are required to be U.S. citizens. To serve, they must submit an annual confidential financial disclosure report used to determine conflicts of interest as well as a foreign activities questionnaire. Prohibited foreign activities include holding a position or title with a foreign governmental entity (including certain universities), and from receiving compensation and certain gifts from a foreign government. E:\FR\FM\11FEN1.SGM 11FEN1

Agencies

[Federal Register Volume 85, Number 28 (Tuesday, February 11, 2020)]
[Notices]
[Page 7774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02637]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Drug 
Discovery for the Nervous System Study Section, February 27, 2020 to 
February 28, 2020, 8:00 a.m. to 6:00 p.m., at the Holiday Inn Bayside, 
4875 North Harbor Drive San Diego, CA 92106 which was published in the 
Federal Register on January 31, 2020, 85 FR 5672.
    This meeting notice is amended to change the meeting date from 
February 27-28, 2020 to February 27, 2020. The meeting location and 
time remain the same. The meeting is closed to the public.

    Dated: February 4, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-02637 Filed 2-10-20; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.